Propanc Biopharma, Inc.

PPCB ·Healthcare, Drug Manufacturers - General, Australia

SEC Filings

Form	Filed	Description
10-Q	May 8, 2017
424B3	Apr 26, 2017
8-K	Apr 26, 2017
8-K	Apr 5, 2017
8-K	Mar 31, 2017	8-K
8-K	Mar 21, 2017	FORM 8-K
DEF 14C	Mar 13, 2017	DEF 14C
PRE 14C	Mar 3, 2017	PRE 14C
8-K	Feb 23, 2017	8-K
10-Q	Feb 14, 2017	FORM 10-Q
424B3	Feb 7, 2017	424B3
424B3	Feb 7, 2017	424B3
8-K	Feb 3, 2017	FORM 8-K
424B3	Jan 6, 2017	424B3
424B3	Jan 6, 2017	424B3
8-K	Dec 30, 2016	FORM 8-K
RW	Dec 12, 2016	RW
424B3	Dec 12, 2016	424B3
424B3	Dec 12, 2016	424B3
8-K	Dec 7, 2016	8-K
8-K	Nov 23, 2016	FORM 8-K
424B3	Nov 18, 2016	424B3
424B3	Nov 18, 2016	424B3
10-Q	Nov 10, 2016	10-Q
EFFECT	Oct 18, 2016

← Newer Page 13 of 18 · 436 filings Older →